Special Issue "The Molecular and Cellular Basis for Parkinson's Disease"
Deadline for manuscript submissions: closed (31 March 2019).
A printed edition of this Special Issue is available here.
Interests: neurology; psychiatry; pain; Parkinson's disease; multiple sclerosis
Special Issues and Collections in MDPI journals
Special Issue in Cells: The Molecular and Cellular Basis for Parkinson’s Disease 2020
Special Issue in NeuroSci: The Molecular and Cellular Basis for Parkinson’s Disease 2021
Special Issue in Biomolecules: The Molecular and Cellular Basis for Parkinson’s Disease 2021
Special Issue in Cells: The Molecular and Cellular Basis for Parkinson’s Disease 2021
Special Issue in Biomolecules: In Honor of the 80th Birthday of Professor Peter Riederer
The focus on dopamine-sensitive motor symptoms, in association with improvement of motor complications in the heterogeneous disease entity Parkinson's disease, leads to a certain standstill in research.
This Special Issue aims to provide new concepts and new ideas on the pathogenesis, genetics, and clinical maintenance of Parkinson's disease and related disorders. Not only new experimental findings, but also clinical outcomes, case series, and research on alternative, non-pharmacological therapies, will be considered.
The objective is to bridge the currently-increasing gap between experimental and clinical research on Parkinson's disease and related disorders.
Prof. Thomas Müller
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Bridge between experimental and clinical research in PD
- Disease modification in PD
- Mechanisms of chronic neurodegeneration
- Pros and cons of animal models in PD
- Microbiome research in PD
- Alternative therapies in PD
- Non-pharmacological therapies in PD